703 related articles for article (PubMed ID: 29202655)
1. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655
[TBL] [Abstract][Full Text] [Related]
2. Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression.
Hochschild A; Keilp JG; Madden SP; Burke AK; Mann JJ; Grunebaum MF
J Affect Disord; 2022 Mar; 300():10-16. PubMed ID: 34953926
[TBL] [Abstract][Full Text] [Related]
3. Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial.
Grunebaum MF; Ellis SP; Keilp JG; Moitra VK; Cooper TB; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
Bipolar Disord; 2017 May; 19(3):176-183. PubMed ID: 28452409
[TBL] [Abstract][Full Text] [Related]
4. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Wilkinson ST; Ballard ED; Bloch MH; Mathew SJ; Murrough JW; Feder A; Sos P; Wang G; Zarate CA; Sanacora G
Am J Psychiatry; 2018 Feb; 175(2):150-158. PubMed ID: 28969441
[TBL] [Abstract][Full Text] [Related]
5. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
Price RB; Iosifescu DV; Murrough JW; Chang LC; Al Jurdi RK; Iqbal SZ; Soleimani L; Charney DS; Foulkes AL; Mathew SJ
Depress Anxiety; 2014 Apr; 31(4):335-43. PubMed ID: 24668760
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation.
Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC; Chen LF; Li WC; Chen MH
Int J Neuropsychopharmacol; 2023 May; 26(5):331-339. PubMed ID: 36966411
[TBL] [Abstract][Full Text] [Related]
7. The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study.
Feeney A; Hock RS; Freeman MP; Flynn M; Hoeppner B; Iosifescu DV; Trivedi MH; Sanacora G; Mathew SJ; Debattista C; Ionescu DF; Fava M; Papakostas GI
Eur Neuropsychopharmacol; 2021 Aug; 49():122-132. PubMed ID: 34090255
[TBL] [Abstract][Full Text] [Related]
8. Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.
Zhou Y; Lan X; Wang C; Zhang F; Liu H; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y
J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):507-518. PubMed ID: 37414272
[TBL] [Abstract][Full Text] [Related]
9. Effects of Ketamine Versus Midazolam on Neurocognition at 24 Hours in Depressed Patients With Suicidal Ideation.
Keilp JG; Madden SP; Marver JE; Frawley A; Burke AK; Herzallah MM; Gluck M; Mann JJ; Grunebaum MF
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34727422
[No Abstract] [Full Text] [Related]
10. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
[TBL] [Abstract][Full Text] [Related]
11. Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting.
Sinyor M; Williams M; Belo S; Orser B; Vincent M; Mah L; Zarate C; Castel S; Levitt AJ; Schaffer A
J Affect Disord; 2018 Dec; 241():103-109. PubMed ID: 30107350
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
[TBL] [Abstract][Full Text] [Related]
13. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
[TBL] [Abstract][Full Text] [Related]
14. A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine.
Bloomfield-Clagett B; Ballard ED; Greenstein DK; Wilkinson ST; Grunebaum MF; Murrough JW; Mathew SJ; Phillips JL; Fava M; Sanacora G; Zarate CA
Int J Neuropsychopharmacol; 2022 Oct; 25(10):827-838. PubMed ID: 35994774
[TBL] [Abstract][Full Text] [Related]
15. Acute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial.
Sajid S; Galfalvy HC; Keilp JG; Burke AK; Mann JJ; Grunebaum MF
Int J Neuropsychopharmacol; 2024 Apr; 27(4):. PubMed ID: 38573154
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation.
Zhan Y; Zhang B; Zhou Y; Zheng W; Liu W; Wang C; Li H; Chen L; Yu L; Walter M; Li M; Li MD; Ning Y
J Affect Disord; 2019 May; 251():205-212. PubMed ID: 30927581
[TBL] [Abstract][Full Text] [Related]
17. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA
J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403
[TBL] [Abstract][Full Text] [Related]
18. Suicidality in treatment resistant depression: perspective for ketamine use.
Jakuszkowiak-Wojten K; Gałuszko-Węgielnik M; Wilkowska A; Słupski J; Włodarczyk A; Górska N; Szarmach J; Szałach ŁP; Wiglusz MS; Krysta K; Cubała WJ
Psychiatr Danub; 2019 Sep; 31(Suppl 3):258-260. PubMed ID: 31488737
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough JW; Iosifescu DV; Chang LC; Al Jurdi RK; Green CE; Perez AM; Iqbal S; Pillemer S; Foulkes A; Shah A; Charney DS; Mathew SJ
Am J Psychiatry; 2013 Oct; 170(10):1134-42. PubMed ID: 23982301
[TBL] [Abstract][Full Text] [Related]
20. Ketamine metabolite pilot study in a suicidal depression trial.
Grunebaum MF; Galfalvy HC; Choo TH; Parris MS; Burke AK; Suckow RF; Cooper TB; Mann JJ
J Psychiatr Res; 2019 Oct; 117():129-134. PubMed ID: 31415914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
